Shasun Pharmaceuticals trades jubilantly on completing MHRA inspection

30 Aug 2013 Evaluate

Shasun Pharmaceuticals is currently trading at Rs. 62.60, up by 3.90 points or 6.64% from its previous closing of Rs. 58.70 on the BSE.

The scrip opened at Rs. 60.00 and has touched a high and low of Rs. 64.40 and Rs. 59.05 respectively. So far 88264 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 185.90 on 10-Sep-2012 and a 52 week low of Rs. 45.60 on 26-Jun-2013.

Last one week high and low of the scrip stood at Rs. 64.40 and Rs. 57.05 respectively. The current market cap of the company is Rs. 353.90 crore.

The promoters holding in the company stood at 41.97% while Institutions and Non-Institutions held 18.79% and 39.24% respectively.

Shasun Pharmaceuticals, a global pharmaceutical organization offering world class capabilities and facilities has successfully completed MHRA inspection during the third week of August 2013. The main focus of the inspection was to conduct cGMP audit for the formulation facility.

Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R&D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.

 

 

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×